Author: Ken Dropiewski

Novostia Announces New CEO and Secures Additional CHF 5.6 million in Funding

September 17, 2024 07:47 AM Eastern Daylight Time LAUSANNE, Switzerland–(BUSINESS WIRE)–Novostia, a pioneering medical technology company, specializing in the development of a disruptive heart valve prosthesis, at clinical stage, today announces a leadership transition alongside the successful completion of a CHF 5.6 million fund raise to further accelerate the company’s […]

Market Expansion for XARELTO in Peripheral Artery Disease Treatment through 2032: Forward-looking Insights and Sales Forecasts, Dynamics and Emerging Therapies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “XARELTO Market Size, Forecast, and Market Insight – 2032” report has been added to ResearchAndMarkets.com’s offering. “XARELTO Market Size, Forecast, and Market Insight – 2032” Post this The latest industry report provides a thorough analysis of the potential growth and impact of XARELTO for the treatment of Peripheral Artery Disease (PAD) in […]

ZONTIVITY Emerges as a Key Player in the Treatment of Peripheral Artery Disease with Promising Market Forecast Through 2032 – ResearchAndMarkets.com

September 17, 2024 12:09 PM Eastern Daylight Time DUBLIN–(BUSINESS WIRE)–The “ZONTIVITY Market Size, Forecast, and Market Insight – 2032” report has been added to ResearchAndMarkets.com’s offering. “ZONTIVITY Market Size, Forecast, and Market Insight – 2032” Post this ZONTIVITY, known for its efficacy in reducing thrombotic cardiovascular events, emerges as a significant pharmaceutical agent in […]

Philips announces FDA approval for enhanced LumiGuide guidewire and marks the 1000th patient treated with its breakthrough 3D device guidance technology

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of the 160cm FDA approved version of its unique LumiGuide endovascular navigation wire. This enhanced LumiGuide guidewire, which utilizes the company’s breakthrough Fiber Optic RealShape (FORS) technology, was used for the first time on a patient by Professor and vascular surgeon Carlos Timaran, MD, an internationally recognized expert in advanced endovascular techniques. He used the technology during a complex aortic aneurism repair operation, marking the 1000th patient treated milestone using FORS technology since first clinical use of the technology in 2020. The introduction of a longer FORS-enabled LumiGuide Navigation Wire enables US clinicians to visualize a broader range of catheters and expands usage of this technology to patients in America treated in centers equipped with LumiGuide.

Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies – Lightning Flash™ 2.0 and Lightning Bolt™ 7 – in Europe

Latest computer assisted vacuum thrombectomy (CAVT) technologies combine superior catheter design with the latest dual clot detection computer algorithms designed to restore blood flow quickly Lightning Flash™ 2.0 will be the most advanced thrombectomy system on the European market to address venous and pulmonary thrombus Lightning Bolt™ 7 is designed […]